For their OTC business, the most innovative pharma companies are following consumer products companies: capturing vast amounts of demand-related information which is then fed into sophisticated ...

“We feel that OTC has a lot of potential for growth. In fact, it can grow a lot faster than the pharma business in the coming years,” adds Juneja, who feels that this segment should have been ...

According to Reuters, one thing Takeda will not be doing is selling its over-the-counter (OTC) business as a quick ... reported that Weber believes that pharma mega-mergers have come back into ...

The business of over-the-counter pharmaceuticals is complex due to the various FDA approvals required. The FDA’s approval process for OTC pharmaceuticals involves multiple stages and types of ...

India's MedPlus Health Services reported a surge in third-quarter profit on Friday, driven by store expansions and strong demand for over-the-counter medicines.

In a report released yesterday, Miyabi Yamakita from Jefferies maintained a Hold rating on Medipal Holdings (MEPDF – Research Report), with a ...

PBSV READ THE FULL PBSV RESEARCH REPORT Pharma-Bio Serv (OTC:PBSV) announced results for the year ended October 31, 2024. The headline revenue and earnings releases were below expectations quarter, ...

Pharma major Mankind Pharma on Thursday reported ... 30% YoY revenue growth in OTC business supported by strategic initiatives undertaken last year. The integration of BSV is on track, with ...